Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 147,581 shares of the stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $10.28, for a total value of $1,517,132.68. Following the completion of the sale, the insider now owns 10,738,564 shares in the company, valued at approximately $110,392,437.92. The trade was a 1.36 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.
Paragon 28 Trading Down 3.7 %
Shares of NYSE:FNA traded down $0.39 during mid-day trading on Friday, hitting $10.04. The stock had a trading volume of 862,267 shares, compared to its average volume of 613,874. Paragon 28, Inc. has a 12-month low of $4.65 and a 12-month high of $14.79. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.60 and a current ratio of 3.50. The company has a market cap of $840.55 million, a PE ratio of -14.09 and a beta of 1.01. The company’s 50 day moving average is $6.66 and its 200-day moving average is $7.25.
Paragon 28 (NYSE:FNA – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The company reported ($0.15) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.01. The business had revenue of $62.30 million for the quarter, compared to the consensus estimate of $60.58 million. Paragon 28 had a negative return on equity of 37.90% and a negative net margin of 25.31%. Paragon 28’s revenue for the quarter was up 18.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.10) earnings per share. On average, sell-side analysts predict that Paragon 28, Inc. will post -0.66 EPS for the current year.
Institutional Inflows and Outflows
Analysts Set New Price Targets
Several research firms have recently commented on FNA. Piper Sandler reissued an “overweight” rating and issued a $12.00 price target (down from $15.00) on shares of Paragon 28 in a report on Friday, August 9th. Canaccord Genuity Group lowered their price target on Paragon 28 from $17.00 to $15.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Finally, Needham & Company LLC increased their price target on shares of Paragon 28 from $11.00 to $13.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $15.60.
View Our Latest Stock Analysis on FNA
Paragon 28 Company Profile
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Featured Articles
- Five stocks we like better than Paragon 28
- Basic Materials Stocks Investing
- Tesla Investors Continue to Profit From the Trump Trade
- The How and Why of Investing in Gold Stocks
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- Retail Stocks Investing, Explained
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.